How to determine the optimal treatment timing in chronic HBV infection patients with normal ALT and positive HBeAg?
Main Author: | ZHAO Hong |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2021-06-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/cn/article/doi/10.3969/j.issn.1001-5256.2021.06.012 |
Similar Items
-
Correlations of HBV Genotypes, Mutations Affecting HBeAg Expression and HBeAg/ anti-HBe Status in HBV Carriers
Published: (2006-01-01) -
Viral Biomarkers in Chronic HBeAg Negative HBV Infection
by: Emilia Hadziyannis, et al.
Published: (2018-09-01) -
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
by: Cheng-Yuan Peng, et al.
Published: (2015-04-01) -
A model to predict liver damage in patients with HBeAg-positive chronic HBV infection
by: Laura Maiocchi, et al.
Published: (2021-06-01) -
Host Factors on Spontaneous HBeAg Seroconversion in Chronic HBV Infected Patients
by: Jia-Feng Wu, et al.
Published: (2010)